CoChat

Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

Open access
Rossello, Xavier, Raposeiras-Roubin, Sergio, Oliva, Belén, Sánchez-Cabo, Fátima, García-Ruíz, José M., Caimari, Francisca, Mendiguren, José M., Lara-Pezzi, Enrique, Bueno, Héctor, Fernández-Friera, Leticia, Fernández-Ortiz, Antonio, Sanz, Javier, Ibanez, Borja, Fuster, Valentin · 2021 · Journal of the American College of Cardiology
Cited by 106

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The metabolic injury caused by protein glycation, monitored as the level of glycated hemoglobin (HbA1c), is not represented in most risk scores (i.e., Systematic Coronary Risk Estimation or atherosclerotic cardiovascular disease risk scale). OBJECTIVES: The purpose of this study was to assess the association between HbA1c and the extent of subclinical atherosclerosis (SA) and to better identify individuals at higher risk of extensive SA using HbA1c on top of key cardiovascular risk factors (CVRFs). METHODS: A cohort of 3,973 middle-aged individuals from the PESA (Progression of Early Subclinical Atherosclerosis) study, with no history of cardiovascular disease and with HbA1c in the nondiabetic range, were assessed for the presence and extent of SA by 2-dimensional vascular ultrasound and noncontrast cardiac computed tomography. RESULTS: After adjusting for established CVRFs, HbA1c showed an association with the multiterritorial extent of SA (odds ratio: 1.05, 1.27, 1.27, 1.36, 1.80, 1.87, and 2.47 for HbA1c 4.9% to 5.0%, 5.1% to 5.2%, 5.3% to 5.4%, 5.5% to 5.6%, 5.7% to 5.8%, 5.9% to 6.0%, and 6.1% to 6.4%, respectively; reference HbA1c ≤4.8%; p < 0.001). The association was significant in all pre-diabetes groups and even below the pre-diabetes cut-off (HbA1c 5.5% to 5.6% odds ratio: 1.36 [95% confidence interval: 1.03 to 1.80]; p = 0.033). High HbA1c was associated with an increased risk of SA in low-risk individuals (p < 0.001), but not in moderate-risk individuals (p = 0.335). Relative risk estimations using Systematic Coronary Risk Estimation or atherosclerotic cardiovascular disease predictors confirmed that inclusion of HbA1c modified the risk of multiterritorial SA in most risk categories. CONCLUSIONS: Routine use of HbA1c can identify asymptomatic individuals at higher risk of SA on top of traditional CVRFs. Lifestyle interventions and novel antidiabetic medications might be considered to reduce both HbA1c levels and SA in individuals without diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2021.03.335

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 106

Metadata

Authors
Rossello, X., Raposeiras-Roubin, S., Oliva, B., Sánchez-Cabo, F., García-Ruíz, J. M., Caimari, F., Mendiguren, J. M., Lara-Pezzi, E., Bueno, H., Fernández-Friera, L., Fernández-Ortiz, A., Sanz, J., Ibanez, B., & Fuster, V.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2021-06
Volume
77
Issue
22
Pages
2777-2791
ISSN
0735-1097 (ISSN-L)
OpenAlex
W3165691177
Cited by
106
References
24
FWCI
12.15
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes. https://app.cochat.ai/papers/10.1016/j.jacc.2021.03.335
The paper
Rossello, X., Raposeiras-Roubin, S., Oliva, B., Sánchez-Cabo, F., García-Ruíz, J. M., Caimari, F., Mendiguren, J. M., Lara-Pezzi, E., Bueno, H., Fernández-Friera, L., Fernández-Ortiz, A., Sanz, J., Ibanez, B., & Fuster, V. (2021). Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2021.03.335

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.